A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN

LESSONS LEARNED. This is the first human interventional study in patients with Cowden syndrome that is driven by inactivation of germline PTEN gene. Single‐agent sirolimus, a mTOR inhibitor, suppressed mTOR signaling in surrogate human tissues without significant toxicity. BACKGROUND. Cowden syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiya, Takefumi, Blumenthal, Gideon M., DeChowdhury, Roopa, Fioravanti, Susan, Ballas, Marc S., Morris, John, Hornyak, Thomas J., Wank, Stephen, Hewitt, Stephen M., Morrow, Betsy, Memmott, Regan M., Rajan, Arun, Dennis, Phillip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975943/
https://www.ncbi.nlm.nih.gov/pubmed/31350329
http://dx.doi.org/10.1634/theoncologist.2019-0514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975943/
https://www.ncbi.nlm.nih.gov/pubmed/31350329
http://dx.doi.org/10.1634/theoncologist.2019-0514

Ejemplares similares